Whittier Trust CO Bristol Myers Squibb CO Transaction History

Whittier Trust CO

$7.37 Billion
Q3 2024

A detailed history of Whittier Trust CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Whittier Trust CO holds 75,015 shares of BMY stock, worth $4.22 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

75,015

Previous 81,344 7.78%

Holding current value

$4.22 Million

Previous $3.38 Million 14.92%

% of portfolio

0.05%

Previous 0.05%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$39.66 - $51.75 $251,008 - $327,525	-6,329 Reduced 7.78%	75,015 $3.88 Million
Q2 2024 Jul 26, 2024	SELL	$40.25 - $52.99 $291,933 - $384,336	-7,253 Reduced 8.19%	81,344 $3.38 Million
Q1 2024 May 02, 2024	BUY	$47.98 - $54.4 $929,948 - $1.05 Million	19,382 Added 28.0%	88,597 $4.8 Million
Q4 2023 Jan 11, 2024	SELL	$48.48 - $57.85 $1.89 Million - $2.26 Million	-39,001 Reduced 36.04%	69,215 $3.55 Million
Q3 2023 Oct 27, 2023	SELL	$57.89 - $64.73 $31,839 - $35,601	-550 Reduced 0.51%	108,216 $6.28 Million
Q2 2023 Jul 24, 2023	SELL	$63.71 - $70.74 $162,906 - $180,882	-2,557 Reduced 2.3%	108,766 $6.96 Million
Q1 2023 Apr 21, 2023	BUY	$65.71 - $74.53 $91,468 - $103,745	1,392 Added 1.27%	111,323 $7.72 Million
Q4 2022 Jan 25, 2023	SELL	$68.48 - $81.09 $92,790 - $109,876	-1,355 Reduced 1.22%	109,931 $0
Q3 2022 Oct 21, 2022	BUY	$0.13 - $76.84 $127 - $75,380	981 Added 0.89%	111,286 $7.91 Million
Q2 2022 Jul 28, 2022	SELL	$72.62 - $79.98 $102,902 - $113,331	-1,417 Reduced 1.27%	110,305 $8.49 Million
Q1 2022 Apr 29, 2022	SELL	$61.48 - $73.72 $114,475 - $137,266	-1,862 Reduced 1.64%	111,722 $8.16 Million
Q4 2021 Jan 19, 2022	SELL	$53.63 - $62.52 $60,870 - $70,960	-1,135 Reduced 0.99%	113,584 $7.08 Million
Q3 2021 Nov 01, 2021	SELL	$59.17 - $69.31 $304,488 - $356,669	-5,146 Reduced 4.29%	114,719 $6.79 Million
Q2 2021 Jul 29, 2021	BUY	$61.91 - $67.42 $21,916 - $23,866	354 Added 0.3%	119,865 $8.01 Million
Q1 2021 Apr 26, 2021	SELL	$59.34 - $66.74 $7.63 Million - $8.59 Million	-128,653 Reduced 51.84%	119,511 $7.55 Million
Q4 2020 Jan 29, 2021	BUY	$57.74 - $65.43 $6.55 Million - $7.42 Million	113,410 Added 84.16%	248,164 $15.4 Million
Q3 2020 Oct 30, 2020	BUY	$57.43 - $63.64 $635,290 - $703,985	11,062 Added 8.94%	134,754 $8.12 Million
Q2 2020 Jul 10, 2020	SELL	$54.82 - $64.09 $1.36 Million - $1.59 Million	-24,854 Reduced 16.73%	123,692 $7.27 Million
Q1 2020 Apr 27, 2020	SELL	$46.4 - $67.43 $718,225 - $1.04 Million	-15,479 Reduced 9.44%	148,546 $8.28 Million
Q4 2019 Jan 31, 2020	BUY	$49.21 - $64.19 $2.72 Million - $3.54 Million	55,226 Added 50.76%	164,025 $10.5 Million
Q3 2019 Oct 18, 2019	BUY	$42.77 - $50.71 $378,044 - $448,225	8,839 Added 8.84%	108,799 $5.52 Million
Q2 2019 Jul 23, 2019	BUY	$44.62 - $49.34 $156,303 - $172,838	3,503 Added 3.63%	99,960 $4.53 Million
Q1 2019 Apr 29, 2019	SELL	$45.12 - $53.8 $2.69 Million - $3.21 Million	-59,633 Reduced 38.2%	96,457 $4.6 Million
Q4 2018 Feb 07, 2019	SELL	$48.76 - $63.23 $2.01 Million - $2.6 Million	-41,172 Reduced 20.87%	156,090 $8.11 Million
Q3 2018 Oct 23, 2018	BUY	$55.19 - $62.25 $1.6 Million - $1.81 Million	29,064 Added 17.28%	197,262 $12.2 Million
Q2 2018 Jul 27, 2018	BUY	$50.53 - $62.98 $1.46 Million - $1.82 Million	28,951 Added 20.79%	168,198 $9.31 Million
Q2 2018 Jul 20, 2018	SELL	$50.53 - $62.98 $1.84 Million - $2.3 Million	-36,471 Reduced 20.76%	139,247 $6.75 Million
Q1 2018 May 01, 2018	BUY	$59.92 - $68.98 $6,950 - $8,001	116 Added 0.07%	175,718 $11.1 Million
Q4 2017 Feb 07, 2018	SELL	$59.94 - $65.35 $139,720 - $152,330	-2,331 Reduced 1.31%	175,602 $10.8 Million
Q3 2017 Oct 23, 2017	BUY	$55.23 - $63.74 $9.83 Million - $11.3 Million	177,933	177,933 $11.3 Million

Others Institutions Holding BMY

# of Institutions

2,529

Shares Held

1.47B

Call Options Held

28M

Put Options Held

30.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Whittier Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Whittier Trust CO with notifications on news.

Account

Whittier Trust CO Bristol Myers Squibb CO Transaction History